Psychosomatics 46:244-249, June 2005
© 2005 The Academy of Psychosomatic Medicine
Major Depression and the Use of Electroconvulsive Therapy (ECT) in Lung Transplant Recipients
Geetha Jayaram, M.D., M.B.A., and
Andy Casimir, M.D.
Received Oct. 2, 2003; revision received Aug. 6, 2004; accepted Sept. 13, 2004. From the Department of Psychiatry, The Johns Hopkins Hospital. Address correspondence and reprint requests to Dr. Jayaram, The Johns Hopkins Hospital, Department of Psychiatry, 600 North Wolfe St., Baltimore, MD 21287.
The purpose of this study is to describe the potential risks and benefits of electroconvulsive therapy (ECT) for treatment of depression in lung transplant recipients. The authors performed a record review of depressed patients who underwent lung transplantation at Johns Hopkins Hospital and evaluated their treatment, including ECT. In 9 years, 131 lung transplants were performed, and four patients had been diagnosed with major depression. Of those, two were candidates for ECT, and one received it. This patient’s depression did abate with ECT. ECT, an effective treatment for depression, remains a treatment method of choice for depression in the posttransplant population.
This article has been cited by other articles:
|
|
|
|
 
H. W. Goforth and K. G. Shiry
Electroconvulsive Therapy for Severe Major Depressive Disorder After Orthotopic Liver Transplantation * Case Report
Psychosomatics,
May 1, 2008;
49(3):
271 - 272.
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2005
Academy of Psychosomatic Medicine.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
